Key result
Chemotherapy failed to control a large extraskeletal Ewing sarcoma of the left thigh in a 30-year-old man, leading to tumor enlargement, inoperability, and death from pulmonary metastases.
Why the study?
Extraskeletal Ewing sarcoma lacks specific clinical signs, which delays diagnosis and worsens its poor prognosis, necessitating early diagnosis for better management.
Case Report (n=1)
Extraskeletal Ewing sarcoma is a rare, aggressive tumor with high mortality, highlighting the need for early diagnosis and management.
May prompt consideration of rare sarcomas in young adults with masses; leaves open multicenter validation of imaging protocols.
Extraskeletal Ewing sarcoma is a rare tumor mainly affecting young people, of poor prognosis with very high mortality rates especially in metastatic forms. It can affect different locations, without specific clinical signs, which delays the diagnosis. Imaging plays an important role for diagnosis, staging, preoperative assessment and surveillance. The diagnosis should be set early to a better management. We report a case of a 30-year-old man with a large extraskeletal Ewing sarcoma of the left thigh. The patient was initially treated with chemotherapy. Unfortunately, the tumor has increased in size making surgery impossible. The patient ultimately died of pulmonary metastases.
No takes yet. Share an insight, caveat, or question.
Nasri et al. (2022) conducted a case report in Extraskeletal Ewing sarcoma (n=1). Chemotherapy was evaluated. Chemotherapy failed to control a large extraskeletal Ewing sarcoma of the left thigh in a 30-year-old man, leading to tumor enlargement, inoperability, and death from pulmonary metastases.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: